These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer. Kaifi JT, Yekebas EF, Schurr P, Obonyo D, Wachowiak R, Busch P, Heinecke A, Pantel K, Izbicki JR. J Natl Cancer Inst; 2005 Dec 21; 97(24):1840-7. PubMed ID: 16368946 [Abstract] [Full Text] [Related]
3. Survival after esophageal resection for carcinoma: the importance of the histologic cell type. Alexiou C, Khan OA, Black E, Field ML, Onyeaka P, Beggs L, Duffy JP, Beggs DF. Ann Thorac Surg; 2006 Sep 21; 82(3):1073-7. PubMed ID: 16928541 [Abstract] [Full Text] [Related]
5. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma. Sasaki K, Natsugoe S, Ishigami S, Matsumoto M, Okumura H, Setoyama T, Uchikado Y, Kita Y, Tamotsu K, Hanazono K, Owaki T, Aikou T. Oncol Rep; 2009 Jan 21; 21(1):65-71. PubMed ID: 19082444 [Abstract] [Full Text] [Related]
7. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis. Porte H, Triboulet JP, Kotelevets L, Carrat F, Prévot S, Nordlinger B, DiGioia Y, Wurtz A, Comoglio P, Gespach C, Chastre E. Clin Cancer Res; 1998 Jun 21; 4(6):1375-82. PubMed ID: 9626453 [Abstract] [Full Text] [Related]
8. Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining. Gockel I, Domeyer M, Sgourakis GG, Schimanski CC, Moehler M, Kirkpatrick CJ, Lang H, Junginger T, Hansen T. J Surg Oncol; 2009 Sep 01; 100(3):191-8. PubMed ID: 19548259 [Abstract] [Full Text] [Related]
10. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Wang KL, Wu TT, Choi IS, Wang H, Resetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT. Cancer; 2007 Feb 15; 109(4):658-67. PubMed ID: 17211865 [Abstract] [Full Text] [Related]
11. Dickkopf-1 expression as a marker for predicting clinical outcome in esophageal squamous cell carcinoma. Makino T, Yamasaki M, Takemasa I, Takeno A, Nakamura Y, Miyata H, Takiguchi S, Fujiwara Y, Matsuura N, Mori M, Doki Y. Ann Surg Oncol; 2009 Jul 15; 16(7):2058-64. PubMed ID: 19408050 [Abstract] [Full Text] [Related]
12. Expression of CXCL12 and its receptor CXCR4 correlates with lymph node metastasis in submucosal esophageal cancer. Sasaki K, Natsugoe S, Ishigami S, Matsumoto M, Okumura H, Setoyama T, Uchikado Y, Kita Y, Tamotsu K, Sakurai T, Owaki T, Aikou T. J Surg Oncol; 2008 Apr 01; 97(5):433-8. PubMed ID: 18176915 [Abstract] [Full Text] [Related]
16. Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis. Kato H, Nakajima M, Masuda N, Faried A, Sohda M, Fukai Y, Miyazaki T, Fukuchi M, Tsukada K, Kuwano H. J Surg Oncol; 2005 May 01; 90(2):89-94. PubMed ID: 15844180 [Abstract] [Full Text] [Related]
17. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors? Bollschweiler E, Baldus SE, Schröder W, Schneider PM, Hölscher AH. J Surg Oncol; 2006 Oct 01; 94(5):355-63. PubMed ID: 16967455 [Abstract] [Full Text] [Related]
19. Expression and prognostic value of MG7-Ag in patients with surgically resectable esophageal squamous cell carcinoma. Zhao Y, Jiang Y, Wang R, Zheng X, Wang X, Jin B, Lu Y, Qiao T, Hong L, Fan D. Ann Surg Oncol; 2007 Sep 01; 14(9):2621-7. PubMed ID: 17570016 [Abstract] [Full Text] [Related]